Other disease associations with non-alcoholic fatty liver disease (NAFLD)

被引:39
|
作者
Allard, JP [1 ]
机构
[1] Univ Toronto, Toronto Gen Hosp, Toronto, ON M5G 2C4, Canada
关键词
non-alcoholic steatohepatitis; jejunoileal bypass; obesity; parenteral nutrition; drugs; malnutrition;
D O I
10.1053/bega.2002.0330
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Non-alcoholic fatty liver disease (NAFLD) is usually seen in middle-aged women with obesity, non-insulin-dependent diabetes mellitus and/or hyperlipidaemia. NAFLD has also been associated with other conditions. Surgical procedures to treat obesity such as jejunoileal bypass and gastroplasty as well as massive small bowel resection have been associated with NAFLD. Mechanisms such as rapid weight loss, certain nutritional deficiencies and bacterial overgrowth have been proposed. Other nutritional conditions such as extreme malnutrition and total parenteral nutrition can also cause NASH. This can be due to abnormal glucose and fat metabolism, deficiencies like carnitine, essential fatty acid and choline or, in the case of parenteral nutrition, excess of calories, glucose or lipids. Several drugs have also been implicated as well as some inborn errors of metabolism and, more rarely, other diseases.
引用
收藏
页码:783 / 795
页数:13
相关论文
共 50 条
  • [31] Non-alcoholic Fatty Liver Disease (NAFLD) Gastroenterologists demand Policies to control Fatty Liver Disease
    不详
    ERNAHRUNGS UMSCHAU, 2022, 69 (01): : S7 - S7
  • [32] Fatty Liver Index (FLI) in Predicting Non-alcoholic Fatty Liver Disease (NAFLD)
    Dehnavi, Zahra
    Razmpour, Farkhonde
    Naseri, Mahmoud Belghaisi
    Nematy, Mohsen
    Alamdaran, Seyed Ali
    Vatanparast, Hassan Ali
    Nezhad, Mohsen Azimi
    Abbasi, Bita
    Ganji, Azita
    HEPATITIS MONTHLY, 2018, 18 (02)
  • [33] Leptin as a marker of liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Petrovic, LM
    Alba, LM
    Lindor, KD
    Talwakar, JA
    Angulo, P
    LABORATORY INVESTIGATION, 2003, 83 (01) : 283A - 283A
  • [34] In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
    Kanuri, Giridhar
    Bergheim, Ina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (06): : 11963 - 11980
  • [35] Non-alcoholic fatty liver disease (NAFLD) models in drug discovery
    Cole, Banumathi K.
    Feaver, Ryan E.
    Wamhoff, Brian R.
    Dash, Ajit
    EXPERT OPINION ON DRUG DISCOVERY, 2018, 13 (02) : 193 - 205
  • [36] Non-alcoholic fatty liver disease (NAFLD) among underweight adults
    Fahim, Shah Mohammad
    Chowdhury, Muhammad Abdul Baker
    Alam, Shahinul
    CLINICAL NUTRITION ESPEN, 2020, 38 : 80 - 85
  • [37] Leptin as a marker of liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Petrovic, LM
    Alba, LM
    Lindor, KD
    Talwakar, JA
    Angulo, P
    MODERN PATHOLOGY, 2003, 16 (01) : 283A - 283A
  • [38] Liver Biopsy and Non-alcoholic Fatty Liver Disease (NAFLD) in Bariatric Patients
    Kanakala, V.
    Chattopadhyay, D.
    Sarkar, R.
    Balupuri, S.
    Small, P. K.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 285 - 285
  • [39] Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Carneros, David
    Lopez-Lluch, Guillermo
    Bustos, Matilde
    NUTRIENTS, 2020, 12 (11) : 1 - 23
  • [40] Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)
    Parameswaran, Madhangi
    Hasan, Hamzah A.
    Sadeque, Jafor
    Jhaveri, Sharan
    Avanthika, Chaithanya
    Arisoyin, Abimbola E.
    Dhanani, Maulik B.
    Rath, Swaroopa M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)